chevron_leftBack
As of 24 April 2025, Ipca Laboratories Ltd. has a market cap of $4.29B USD, ranking #3186 globally and #226 in India. It ranks #274 in the Healthcare sector, and #45 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$4.29BUSD
366.22B INR
Enterprise Value
$4.49BUSD
383.38B INR
Revenue (TTM)
$1.02BUSD
87.27B INR
EBITDA (TTM)
$186.5MUSD
15.91B INR
Net Income (TTM)
$85.49MUSD
7.29B INR
EBITDA Margin
18%
Profit Margin
8.4%
PE Ratio
50.2
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Pranay Godha
open_in_new
Employees
17,335
Founded
1949
Website
ipca.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.9% | 1.8% | 1.9% | -8% | -9.7% | 7.9% |
Upcoming Earnings
Earnings Date
Tue, May 27
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
IPCALAB
Ipca Laboratories Ltd
ISIN: INE571A01038
Shares Out.:
Shares Outstanding:
253.704M1
Shares Float:
130.478M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.47K INR | |
|
524494
(IPCALAB)
Ipca Laboratories Ltd
ISIN: INE571A01038
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.4K INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Ipca Laboratories Ltd.
Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
